Follow
Robin Beekhof
Robin Beekhof
Cancer Center Amsterdam
Verified email at amsterdamumc.nl - Homepage
Title
Cited by
Cited by
Year
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
R Beekhof, C van Alphen, AA Henneman, JC Knol, TV Pham, F Rolfs, ...
Molecular systems biology 15 (4), e8250, 2019
752019
Ferritin heavy chain in triple negative breast cancer: a favorable prognostic marker that relates to a cluster of differentiation 8 positive (CD8+) effector T-cell response
NQ Liu, T De Marchi, AM Timmermans, R Beekhof, ...
Molecular & Cellular Proteomics 13 (7), 1814-1827, 2014
512014
Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection
M Labots, JC van der Mijn, R Beekhof, SR Piersma, RR de Goeij-de Haas, ...
Journal of proteomics 162, 99-107, 2017
312017
Phosphotyrosine-based phosphoproteomics for target identification and drug response prediction in AML cell lines
C van Alphen, J Cloos, R Beekhof, DGJ Cucchi, SR Piersma, JC Knol, ...
Molecular & Cellular Proteomics 19 (5), 884-899, 2020
292020
Peptide-mediated ‘miniprep’isolation of extracellular vesicles is suitable for high-throughput proteomics
JC Knol, I de Reus, T Schelfhorst, R Beekhof, M de Wit, SR Piersma, ...
EuPA Open Proteomics 11, 11-15, 2016
292016
Peptide-mediated ‘miniprep’isolation of extracellular vesicles is suitable for high-throughput proteomics
JC Knol, I de Reus, T Schelfhorst, R Beekhof, M de Wit, SR Piersma, ...
EuPA Open Proteomics 11, 11-15, 2016
292016
Proteomic analysis of miR-195 and miR-497 replacement reveals potential candidates that increase sensitivity to oxaliplatin in MSI/P53wt colorectal cancer cells
D Poel, LNC Boyd, R Beekhof, T Schelfhorst, TV Pham, SR Piersma, ...
Cells 8 (9), 1111, 2019
262019
Kinase inhibitor treatment of patients with advanced cancer results in high tumor drug concentrations and in specific alterations of the tumor phosphoproteome
M Labots, TV Pham, RJ Honeywell, JC Knol, R Beekhof, ...
Cancers 12 (2), 330, 2020
142020
.(2019) INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
R Beekhof, C van Alphen, AA Henneman, JC Knol, TV Pham, F Rolfs, ...
Mol. Syst. Biol 15, e8250, 0
5
Phosphoproteomics of patient-derived xenografts identifies targets and markers associated with sensitivity and resistance to EGFR blockade in colorectal cancer
R Beekhof, A Bertotti, F Böttger, V Vurchio, F Cottino, ER Zanella, ...
Science Translational Medicine 15 (709), eabm3687, 2023
32023
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active phosphokinases
TV Pham, R Beekhof, C van Alphen, JC Knol, AA Henneman, F Rolfs, ...
bioRxiv, 259192, 2018
22018
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho) proteomics
H van der Wijngaart, R Beekhof, JC Knol, AA Henneman, ...
Clinical Proteomics 20 (1), 49, 2023
2023
Prediction of response to sunitinib in patients with advanced renal cell carcinoma (RCC) using mass spectrometry-based (phospho) proteomics.
H van der Wijngaart, R Beekhof, JC Knol, AA Henneman, ...
Journal of Clinical Oncology 39 (15_suppl), e16556-e16556, 2021
2021
Comparison of phosphoproteomic profiles in left-and right-sided colorectal cancers.
T Buffart, R Beekhof, R van den Oord, RR de Haas, TV Pham, H Dekker, ...
Journal of Clinical Oncology 37 (4_suppl), 582-582, 2019
2019
Peptide-mediated ‘miniprep’isolation of extracellular vesicles for high-throughput proteomics; method evaluation and application in colon cancer
CR Jimenez, M de Wit, JC Knol, I de Reus, T Schelfhorst, L Bishop-Currey, ...
Cancer Research 76 (14_Supplement), 3885-3885, 2016
2016
Mapping the metastatic colorectal cancer phospho-proteome for predicting response to cetuximab
R Beekhof, M Labots, JC Knol, TRA Schelfhorst, N van Grieken, ...
Cancer Research 76 (14_Supplement), 880-880, 2016
2016
Mass spectrometry-based phosphoproteomics of tumor needle biopsies from patients (pts) with advanced solid tumors during treatment with protein kinase inhibitors.
M Labots, R Beekhof, JC Knol, M Neerincx, RR de Haas, H Dekker, ...
Journal of Clinical Oncology 34 (15_suppl), 11609-11609, 2016
2016
Phosphoproteomics scaled-down to tumor biopsies for future TKI treatment selection
M Labots, JC Van der Mijn, SR Piersma, RR De Haas, R Beekhof, ...
Cancer Research 75 (15_Supplement), 2007-2007, 2015
2015
Copyright 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
NQ Liu, T De Marchi, AM Timmermans, R Beekhof, A MAC
2012
Abbott, Derek, 852 Aljabr, Waleed, 793 Armstrong, Stuart D., 793 Arvan, Peter, 852
M Avino, JP Babeu, B Beadle, I Bederman, R Beekhof, B Bodenmiller, ...
The system can't perform the operation now. Try again later.
Articles 1–20